Pure Global
NCT06384274

The Effect of Emotional Freedom Technique and Virtual Reality Glasses on Anxiety and Vital Signs

The Effect of Emotional Freedom Technique and Virtual Reality Glasses on Anxiety and Vital Signs in Individuals Receiving Hyperbaric Oxygen Therapy: Randomized Controlled Trials
Necmettin Erbakan University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Anxiety
Drug/Device/Intervention
Emotional Freedom Technique
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Necmettin Erbakan University
Location
Konya, Turkey
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2024
End date
Jun 01, 2025
Enrollment
75 participants
Primary outcome

State Anxiety Inventory (STAI)

Summary

The aim of the study was to examine the effects of the emotional freedom technique and
 virtual reality glasses applied to individuals receiving hyperbaric oxygen therapy for the
 first time on anxiety and vital signs. The hypotheses of this research are that there is a
 difference between the emotional liberation technique and virtual reality glasses groups and
 the control group in terms of anxiety and vital signs.

ICD-10 classifications
Anxiety disorder, unspecifiedOther anxiety disordersPhobic anxiety disordersPhobic anxiety disorder, unspecifiedGeneralized anxiety disorder
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06384274
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06384274 through Pure Global AI's free database. This phase not specified trial is sponsored by Necmettin Erbakan University and is currently Not yet recruiting. The study focuses on Anxiety. Target enrollment is 75 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.